TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$8.20M2013: -$13.17M2014: -$37.03M2015: -$60.72M2016: -$135.75M2017: -$73.67M2018: -$143.59M2019: -$279.66M2020: -$384.84M2021: -$282.02M2022: -$94.23M2023: -$51.92M2024: -$69.41M2025: -$5.34M-$5.34M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$5.34M+92.3%
2024-$69.41M-33.7%
2023-$51.92M+44.9%
2022-$94.23M+66.6%
2021-$282.02M+26.7%
2020-$384.84M-37.6%
2019-$279.66M-94.8%
2018-$143.59M-94.9%
2017-$73.67M+45.7%
2016-$135.75M-123.6%
2015-$60.72M-63.9%
2014-$37.03M-181.3%
2013-$13.17M-60.7%
2012-$8.20M—